NVS Novartis AG
- Stocks
- Healthcare
- NYSE: NVS
Price (delayed)
$125.5
Market cap
$241.71B
P/E Ratio
17.03
Dividend/share
$3.87
EPS
$7.37
Enterprise value
$264.18B
Relative Growth:
50
Relative Strength:
63
Relative Valuation:
60
Relative Profitability:
93
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world
Highlights
The gross profit rose by 15% year-on-year and by 2.1% since the previous quarter
Novartis AG's revenue has increased by 13% YoY and by 2.1% QoQ
The quick ratio is down by 26% year-on-year but it is up by 14% since the previous quarter
The company's net income fell by 18% YoY but it rose by 5% QoQ
Key stats
What are the main financial stats of NVS
Market
Valuations
Earnings
Shares outstanding
1.93B
Market cap
$241.71B
Enterprise value
$264.18B
Price to earnings (P/E)
17.03
Price to book (P/B)
5.48
Price to sales (P/S)
4.29
PEG
N/A
EV/EBIT
15.06
EV/EBITDA
9.37
EV/Sales
4.69
Revenue
$56.37B
Gross profit
$42.96B
Operating income
$17.56B
Net income
$14.39B
EBIT
$17.54B
EBITDA
$28.18B
Free cash flow
$19.64B
Per share
Balance sheet
Liquidity
EPS
$7.37
EPS diluted
$7.3
Free cash flow per share
$10.19
Book value per share
$22.9
Revenue per share
$29.27
TBVPS
$27.36
Total assets
$107.29B
Total liabilities
$62.54B
Debt
$32.02B
Equity
$44.33B
Working capital
-$3.8B
Debt to equity
0.72
Current ratio
0.88
Quick ratio
0.58
Net debt/EBITDA
0.8
Margins
Efficiency
Dividend
EBITDA margin
50%
Gross margin
76.2%
Net margin
25.5%
Operating margin
31.1%
Return on assets
13.9%
Return on equity
34.1%
Return on invested capital
41.5%
Return on capital employed
23.3%
Return on sales
31.1%
Dividend yield
3.08%
DPS
$3.87
Payout ratio
52.5%
NVS stock price
How has the Novartis AG stock price performed over time
Intraday
0.39%
1 week
3.04%
1 month
-5.2%
1 year
14.74%
YTD
28.97%
QTD
-2.14%
Financial performance
How have Novartis AG's revenue and profit performed over time
Revenue
$56.37B
Gross profit
$42.96B
Operating income
$17.56B
Net income
$14.39B
Gross margin
76.2%
Net margin
25.5%
NVS's operating income is up by 29% year-on-year and by 5% since the previous quarter
The company's net margin fell by 28% YoY but it rose by 3.2% QoQ
The company's net income fell by 18% YoY but it rose by 5% QoQ
The gross profit rose by 15% year-on-year and by 2.1% since the previous quarter
Price vs fundamentals
How does NVS's price correlate with its fundamentals
Growth
What is Novartis AG's growth rate over time
Valuation
What is Novartis AG stock price valuation
P/E
17.03
P/B
5.48
P/S
4.29
EV/EBIT
15.06
EV/EBITDA
9.37
EV/Sales
4.69
The company's EPS fell by 14% YoY but it rose by 7% QoQ
The stock's P/E is 5% less than its 5-year quarterly average of 18.0
NVS's P/B is 30% above its 5-year quarterly average of 4.2
The company's equity rose by 6% QoQ and by 2.3% YoY
Novartis AG's revenue has increased by 13% YoY and by 2.1% QoQ
The P/S is 4.6% more than the last 4 quarters average of 4.1
Efficiency
How efficient is Novartis AG business performance
Novartis AG's ROA has decreased by 22% YoY but it has increased by 4.5% from the previous quarter
The ROIC has declined by 21% year-on-year but it is up by 3.5% since the previous quarter
The company's return on sales fell by 20% YoY but it rose by 2.6% QoQ
NVS's ROE is down by 17% YoY but it is up by 4.6% QoQ
Dividends
What is NVS's dividend history
DPS
$3.87
Dividend yield
3.08%
Payout ratio
52.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Novartis AG financials performed over time
NVS's total assets is 72% greater than its total liabilities
The quick ratio is down by 26% year-on-year but it is up by 14% since the previous quarter
Novartis AG's current ratio has decreased by 21% YoY but it has increased by 7% QoQ
The company's debt is 28% lower than its equity
The debt to equity has contracted by 8% from the previous quarter and by 2.7% YoY
The company's equity rose by 6% QoQ and by 2.3% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.